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ABSTRACT 
The term “Mediterranean diet” is widely employed to indicate the typical diet of the Countries located on the Mediter- 
ranean sea coast. A growing body of scientific literature pointed out the healthy effects of this diet. In recent years we 
investigated about the protective effects of a regular and moderate wine consumption. As we know, alcoholic and non 
alcoholic wine constituents are responsible of different effects by means of molecular and cell mechanisms. Among the 
non alcoholic components, polyphenols (for example resveratrol and quercetin) were deeply investigated. The aim of 
this review is to underline the effects of a moderate and regular wine drinking in the context of the Mediterranean diet 
in light of the interactions between wine and important dietary factors such as olive oil, fruit and vegetables. 
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1. Introduction 
The term “Mediterranean diet” is greatly employed to in- 
dicate the typical diet of the Countries located on the Me- 
diterranean sea coast [1]. From ancient times, these popu- 
lations were characterized by simple food habits as the 
high intake of whole cereals (pasta, bread, rice), fruits and 
vegetables (up to 400 grams/day in Greece), legumes and 
fish, olive oil as the common source of fats, poor intake of 
meat and dairy products and a moderate, regular wine 
drinking. 
Several data underline the healthy effects of this diet 
[2]. 
In recent years we examined the protective effects of a 
regular and moderate wine consumption on diabetes mel- 
litus [3], hypertension [4], endothelial function [5] and 
chronic renal failure [6]. 
The main goal of this review is to show the effects of a 
moderate and regular wine consumption in the context of 
a healthy diet such the Mediterranean one. For this reason, 
the complex influences exerted by wine on cardiovascular, 
metabolic and renal systems, neurodegenerative diseases 
and cancer must be mentioned. 
2. Wine and Cardiovascular Diseases 
The J-shaped alcohol-mortality curve is well known. Light 
drinkers have about 30% lower cardiovascular morbidity 
and mortality risk than abstainers, with about a 10% lower 
total mortality risk [7]. 
The positive effects arising from alcohol consumption 
could be reached only with 5 years of regular physical ex- 
ercise [8]. Among the different alcoholic beverages, Gron- 
baek [9] demonstrated a reduced relative risk of mortality 
in subjects who daily consumed moderate amounts of wine; 
the same effect was not observed with beer and spirits. 
In 1992 Renaud and De Lorgeril with the worldwide 
known “French paradox” [10] stigmatized such a relation- 
ship. This expression was coined to describe the relatively 
low incidence of cardiovascular disease observed in French 
population, in spite of a high dietary intake of saturated 
fats. Authors postulated that a regular wine consumption 
was responsible of the great difference they observed 
among France and other Northern European Countries in 
terms of cardiovascular mortality. 
There are great amount of works in literature reporting 
the significant inverse relationship between wine drinking 
and cardiovascular mortality and morbidity [11,12]. 
Nowadays, we know that wine exerts its protective ef- 
fects by means of different mechanisms directed towards 
different targets. So to elucidate this effects we have to 
mention the influence of wine on lipoprotein metabolism, 
haemostasis and thrombosis and endothelial function. 
As it is known, wine contains alcohol and non alcoholic 
components: among the latters, polyphenols play a lead- 
ing role in determining wine effects. *Corresponding author. 
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2.1. Lipoprotein Metabolism 
Alcohol consumption leads to higher HDL-cholesterol 
levels, but the same effect was observed in animal models 
with alcohol-free red wine [13]. 
Red wine phenolic extract decrease plasma cholesterol, 
triglyceride and Apo B levels in hamsters [14]. In cell lines 
resveratrol inhibits lipid peroxidation and improves the ef- 
flux by which HDL removes the excess of cholesterol from 
macrophages. Such a process is fundamental for reverse 
cholesterol transport which, on its turn, is on the basis for 
protection against atherosclerosis [15]. 
Polyphenols inhibits LDL oxidation in a more powerful 
manner than vitamin E as demonstrated by Frankel [16]. 
Moreover red wine consumption reduces plasma levels of 
Lp(a) [17] that, as it is known, is able to reduce the fibri- 
nolytic activity. Red wine constituents also inhibit foam- 
cell synthesis [18]. 
Recently, in a double-blind, placebo-controlled trial 
post-infarction patients treated with resveratrol for three 
months showed a significant reduction of LDL cholesterol. 
[19] 
2.2. Haemostasis and Thrombosis 
An inverse relationship between alcohol consumption and 
both fibrinogen and antithrombin has been demonstrated 
[20]; other authors observed a direct association between 
alcohol consumption and protein S [18], ultimately stimu- 
lating the surface-localized endothelial cell fibrinolysis. 
The same group showed is that differently from what 
observed with beer and spirits to which could be due isch- 
aemic events 24 - 48 hours after consumption, wine does 
not exert rebound effects [9]. 
Three glasses a day of red wine can significantly inhibit 
platelet aggregation, more than what observed with grape- 
juice or resveratrol-enriched grape juice, thus underlining 
the role of alcoholic components [21]. Resveratrol, cate- 
chin and quercetin are powerful inhibitors of platelet ag- 
gregation by different mechanisms among which decree- 
sed thromboxane synthesis with consequent reduced acti- 
vation of cyclo- and lipo-oxygenase must be mentioned 
[22]. Many papers strengthened this particular action of 
wine thus leading to consider it an “aspirin-like” com- 
pound [23]. However, results in normal subjects are con- 
troversial and someone did not observed ex vivo the same 
response. This might depend on different factors such bio- 
availability, intestinal clearance or drinking amount [24]. 
2.3. Endothelial Function 
Protection against cardiovascular diseases is exerted by 
wine polyphenols that play an important influence on en- 
dothelium. In animal models and cultured cells different 
authors showed a vasodilating effect elicited by wine [25]. 
On human endothelium wine’s effects are rather contro- 
versial. In human umbilical vein endothelial cells (HUV- 
EC) treated with a red wine polyphenolic extract Leikert 
[26] observed a significant nitric oxide (NO) increase via 
a raised eNOS protein expression. In the same cell line, re- 
sveratrol upregulated eNOS by stimulating promoter and 
transcription factors [27]. From these starting points, many 
studies on human volunteers proved a significant flow- 
mediated dilation (FMD) after consuming a high fat meal 
associated with red wine [28,29]. After the observation of 
an increased FMD even with a dealcoholized red wine, 
some authors hypothesized the so called “Japanese Para- 
dox” [30] with the creation of a tasty and healthy dealcoho- 
lized wine. Unfortunately, such investigations do not take 
account the important social role of the alcoholic bevera- 
ges, expecially wine. 
If we consider that polyphenols are detectable in the 
plasma of non supplemented humans at concentrations 
comparable to those required to induce 50% of maximal 
endothelium-dependent vasorelaxation, it can be hypothe- 
sized that in vivo effective concentrations can be reached 
[31]. 
In more than 300 men and 200 women who underwent 
coronary angiography, Liu et al. [32] showed that alcohol 
consumption was related to a lower risk of severe coro- 
nary stenosis in men, while in patients with angiographi- 
cally documented coronary artery disease, Teragawa et al. 
[33] found that alcohol, if consumed at least once a week, 
positively influenced endothelial function. 
Recently, Magyar showed that post infarction patients, 
treated with resveratrol show a significant improvement 
of endothelial function measured with FMD [19]. 
As we mentioned in our previous papers on this topic 
[3-6], all these data, rather controversial, lead us to think 
that beneficial effects could be due both to polyphenols 
and alcohol. 
Many typical mediterranean foods, like onions, are a 
great source of polyphenols [34]. In fact, Mediterranean 
diet has been shown to reduce endothelial damage and to 
influence the endothelial ability to repair itself [35]. 
2.4. Wine and Hypertension 
Hypertensives, according to WHO estimation [36], are 
about 600 millions and the number of prehypertensives is 
increasing. Hypertension is a common background in 
stroke [36] and a key factor in the progression of kidney 
disease [37]. A direct relationship between alcohol con- 
sumption and arterial hypertension is well documented 
[38] and this kind of association is also confirmed for a 
daily wine consumption greater than 3 glasses [39]. Some 
polyphenols, expecially quercetin (which is largely pre- 
sent in white wines) showed instead anti-hypertensive 
properties. In animal model of experimental hypertension, 
quercetin reduced blood pressure, cardiac and renal hyper- 
trophy and blunted the hypertension-induced vascular 
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remodeling in a dose-dependent manner [40]. In another 
model of salt-hypertensive rats, chronic oral administration 
of quercetin showed the same effects of verapamil on 
systolic blood pressure [41]. 
In the Predimed Study [42], a clinical, multicentric ran- 
domized, controlled trial total polyphenol urinary ex- 
cretion, as biomarker of the total polyphenol intake, was 
measured in more than 500 subjects. This parameter was 
strictly inversely related to the prevalence of both systolic 
and diastolic hypertension. Polyphenols probably reduce 
arterial pressure also thanks to their ability to inhibit an- 
giotensin converting enzyme, as demonstrated by Actis- 
Goretta [43]. 
In light of all these considerations, it’s easy to under- 
stand how the deep, complex interactions between dietary 
factors, wine and their pathophysiological targets could be 
responsible of a reduced cardiovascular risk. 
2.5. Wine and Renal Diseases 
The relationship between wine consumption and kidney 
disease is very interesting if we consider that chronic kid- 
ney disease is associated with accelerated atherosclerotic 
damage and more frequent cardiovascular events. Oxida- 
tive stress and endothelial dysfunction, which are inter- 
related [44], are involved in the pathophysiology of many 
renal diseases [45] In rat models of diabetic nephropathy, 
quercetin showed to be able in reducing the disease pro- 
gression [46]. In human patients with the same chronic 
kidney disease a similar result was obtained with a poly- 
phenol-enriched diet [47]. 
Another wine constituent, the phytoalexin resveratrol, 
showed inhibitory effects on proteinuria, hypoalbumine- 
mia and hyperlipidemia in nephritic rats [48]. Its nephro- 
protective effects were usually ascribed to its ability in 
modulate nitric oxide production and endothelial function. 
In fact it enhances production and activity of endothelial 
nitric oxide synthase (eNOS) [27]. More recently Mannari 
and coworkers [49] hypothesized that nephroprotection 
could be also due to the sirtuin regulation by NO modu- 
lation. Sirtuins are a protein family which is involved in 
several different biological processes, from glucose ho- 
meostasis to aging and cancer. Sirtuin-1 is the most in- 
vestigated member of this family. It is a NAD(+) depen- 
dent deacetylase that regulates body stress responses by 
adjusting cell adaptations [50]. It is widely expressed in 
various tissues (liver, pancreas, muscles, adipose tissue, 
brain). Resveratrol activates sirtuin-1 via an allosteric inter- 
action thus eliciting its effects. 
2.6. Wine and Diabetes Mellitus 
The association between wine consumption and diabetes 
mellitus has been largely examined. From the epidemio- 
logical point of view, Conigrave and coworkers [51] 
showed an inverse linear relationship between daily al- 
cohol intake and diabetes; the corrected relative risk gave 
to white wine the major protective role. More recently, in 
the EPIC-InterAct Study [52] carried out in eight European 
Countries, a moderate alcohol consumption has been as- 
sociated with a lower risk of developing diabetes in fe- 
male population. The same result was not observed in 
males probably due to the different body fat distribution. 
In animal models of metabolic syndrome (Zucker rats), 
Rivera [53] showed that a daily administration of resve- 
ratrol carried out for 4 weeks lead to a reduction of plasma 
glucose levels, triglycerides, total cholesterol, free fatty 
acids, insulin and leptin and a significant decrease of liver 
fat content. These effects were ascribed to the increased 
phosphorylation of AMP-activated protein kinase and ace- 
tyl-CoA carboxylase in the liver of these animals. Further- 
more a significant improve in inflammatory conditions and 
an increased expression of eNOS in the visceral adipose 
tissue of the Zucker rats were noted. 
In diabetic subjects, Ceriello and coworkers [54] some 
years ago showed as a standard meal is associated with a 
decrease of plasma total radical antioxidant power (TR- 
AP); while if red wine is introduced in the same meal, the 
decrease of TRAP was not observed, thus underlining the 
antioxidant role of wine. 
The antioxidant properties of wine polyphenols play a 
role in prevention of long term diabetic complications such 
as neuropathy, nephropathy and retinopathy. In fact poly- 
phenols prevent the accumulation of oxidative/nitrative 
stress products in different body tissues as observed in 
animal models [55]. 
2.7. Wine and Neurodegenerative Diseases 
It has been demonstrated, in various cell culture and ani- 
mal models, that wine polyphenols protect neuronal cells 
by attenuating oxidative stress and cell damage. Regular 
wine consumption has been associated with a reduced in- 
cidence of neurodegenerative diseases. Among the poly- 
phenols, resveratrol has been related with a lower reduc- 
tion of Beta-amyloid via sirtuin-1 actions [50]. Resvera- 
trol also acts on glial inflammation which is strictly in- 
volved in brain damage. In fact it has been demonstrated 
to be implicated in several cell mechanisms that lead to a 
reduced production of glial inflammatory mediators [56]. 
However, as suggested by Albarracin [57] and cowor- 
kers, it remains unclear how these compounds reach the 
brain, what concentrations are necessary, and what bio- 
logically active forms are needed to have beneficial ef- 
fects. Therefore, further research is needed about this 
topic. 
2.8. Wine and Cancer 
The role of wine is controversial. A direct relationship 
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between alcohol consumption and colo-rectal cancer has 
been reported and a similar association was observed for 
what regards liver, pharynx and larynx cancer [58-61]. A 
weaker association was observed between alcohol con- 
sumption and pancreas and neck cancer. No sure data are 
available for other many cancers whilst for what concerns 
the renal cancer a protective role of alcohol has been de- 
monstrated [62]. 
Polyphenols, instead exert a protective role against 
cancer risk. Supposed mechanisms for this protections are: 
reduced expression of pro-oxidant enzymes which are in- 
volved in carcinogenesis; inhibition of transcription fac- 
tor activation; apoptosis; impairment of cancer angio- 
genesis [63]. 
Recently resveratrol has been shown to involved in pain 
control, a crucial topic for cancer patients. In fact, it re- 
gulates nociceptive signaling via inhibition of cyclin-de- 
pendent kinase 5 (cdk5). Resveratrol blocks the TNF α- 
mediated increase in p35 promoter activity thus reducing 
cdk5, which is actually considered a key target molecule 
for analgesia [64]. 
Besides wine, many dietary constituents were associ- 
ated with cancer prevention: olive oil, fish, fruit and vege- 
tables. Considering that all these foods are present in the 
Mediterranean diet, we have to look at this dietary habit as 
the healthiest one for prevention.  
3. Mediterranean Diet 
A great number of observational studies and clinical trials 
investigated about the relationship between dietary habits 
and cardiovascular disease, which is more interesting if 
we consider that the 169 billions of euro is how much car- 
diovascular diseases yearly cost. 
One of the most important study in this field is the 
Seven Countries Study [65] in which a reduced consump- 
tion of saturated fatty acids is considered the leading cause 
of decreased cardiovascular mortality in Mediterranean 
Countries. 
Such an observation was strongly confirmed by Re- 
naud’s so-called “Cretan Miracle” [66]. In fact, Cretan 
people, in spite of their high blood cholesterol levels, 
exhibited a low cardiovascular mortality due, on Renaud’s 
opinion, to their healthy dietary habits, expecially for the 
high consumption of alfa-linolenic acid which is abundant 
in snails and walnuts. 
Mediterranean diet is inversely related with body mass 
index, obesity and hypertension [67], even though its con- 
tribution in carbohydrate intake is high. This is reasonably 
due to many factors: 
‐ The high consumption of fruit and vegetables; fruit 
consumption is inversely associated with cardiovascu- 
lar and cerebrovascular risk both in men and women 
[68,69]. 
‐ The significant intake of olive oil; it’s the leading con- 
stituent of this diet. For its high polyphenols content, it 
has been demonstrated a powerful antiarrythmic, anti- 
inflammatory, antioxidant and vasodilating compound, 
[70]. The favourable effects of olive oil have been 
ascribed to different mechanisms: reduction of LDL- 
cholesterol levels and increase of HDL-cholesterol; 
lower susceptibility of LDLs to oxidation; improved 
endothelial function; better haemostasis and arterial 
pressure control. Olive oil also showed antineoplastic 
properties and ability to protect against neurodegene- 
rative diseases [71]. 
‐ Regular consumption of garlic and onions. The former 
has shown to reduce blood pressure by means of an- 
giotensin converting enzyme inhibiting activity. It also 
improves endothelial function by stimulating nitric 
oxide production and scavenging free radicals. Onions 
have fibrinolytic and hypotensive effects probably due 
to the high content of quercetin that is widely known to 
reduce blood pressure in hypertensives. The effects of 
onions’ consumption are strengthened by the presence 
in the same meal of olive oil and red wine. 
‐ Fish consumption. It has been associated with a re- 
duction of cardiovascular risk. Regular fish intake has 
been inversely related with ischemic stroke. A similar 
relationship is not applicable to hemorrhagic stroke 
because omega-3 have a potential antiaggregant acti- 
vity [72]. Protective effects of fish have been extended 
to cancer, aging and Alzheimer’s disease [73] It sup- 
plies excellent amount of proteins, low saturated fats, 
long-chain and omega-3 polyunsaturated fatty acids 
(PUFA). This topic gained a great attention after the 
observations regarding the myocardial precondition- 
ing [74]. At this regard, diet and healthy lifestyle (that 
is, for example, a regular physical activity [75]) are ac- 
tually considered the most powerful preconditioners to 
reduce the ischemic myocardial damage. Among die- 
tary factors, a diet with an increased omega-3 PUFA 
intake and a poor consumption of saturated fatty acids 
and omega-6 PUFA showed the best results in myo- 
cardial protection against ischemic injury [76]. The 
Mediterranean diet typically has a fatty acids profile 
very similar to the ideal one. Moreover, the lack in this 
diet of great amounts of omega-6 PUFA is more inte- 
resting if we consider that these fatty acids showed 
strong effects in enhancing breast cancer [77]. 
4. Conclusions 
A regular and moderate wine consumption, associated 
with a simple, healthy diet such the Mediterranean one, is 
an advisable life habit. Beyond theoretical hypotheses, 
polyphenols could find clinical applications and in fact 
resveratrol tablets are already available as antiviral. 
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More recently, resveratrol and quercetin have been em- 
ployed in developing drug-eluting polymer coatings for 
endovascular devices. The gradual release of therapeutical 
concentration of these agents is useful to avoid the in-stent 
stenosis [78]. 
In light of all these considerations, a regular and mo- 
derate wine consumption, (The so called “Mediterranean 
way of drinking” of Giocosa and coworkers [79]) accom- 
panied by Mediterranean-style diet and physical activity 
could be considered a wise prescription for healthy and ill 
people. At this regard, to seal its fundamental role in pre- 
ventive strategies, Mediterranean diet obtained in 2010 
the acknowledgment of UNESCO as an Intangible Cul- 
tural Heritage of Humanity. 
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